Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension
Abstract
The quality of clinical trials is essential to advance treatment, inform regulatory decisions and meta-analysis. With the increased incidence of idiopathic intracranial hypertension and the emergence of clinical trials for novel therapies in this condition, the International Headache Society Guidelines for Controlled Clinical Trials in Idiopathic Intracranial Hypertension aims to establish guidelines for designing state-of-the-art controlled clinical trials for idiopathic intracranial hypertension.
Keywords
Idiopathic intracranial hypertension; Pseudotumor cerebri; Randomised control trial
Bibliographic citation
Mollan SP, Fraser CL, Digre KB, Diener H-C, Lipton RB, Juhler M, et al. Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension. Cephalalgia. 2023 Aug;43(8):1–25.
Audience
Professionals
Use this identifier for quote and/or link this document
https://hdl.handle.net/11351/10290This item appears in following collections
- HVH - Articles científics [2476]
- VHIR - Articles científics [1012]
The following license files are associated with this item: